These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10604702)

  • 1. Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA.
    Kalish LA; McKinlay JB
    Urology; 1999 Dec; 54(6):1022-7. PubMed ID: 10604702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific reference ranges for prostate specific antigen-total and free in patients with prostatitis symptoms and patients at risk.
    Battikhi MN; Hussein I
    Int Urol Nephrol; 2006; 38(3-4):559-64. PubMed ID: 17318358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients.
    Battikhi MN
    Prostate Cancer Prostatic Dis; 2003; 6(3):256-60. PubMed ID: 12970732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men.
    Lein M; Koenig F; Jung K; McGovern FJ; Skates SJ; Schnorr D; Loening SA
    Br J Urol; 1998 Aug; 82(2):231-6. PubMed ID: 9722758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific reference ranges for prostate-specific antigen among healthy Syrian men.
    Bakir MA; Abo-daher D
    Int J Biol Markers; 2012 Jul; 27(2):e152-9. PubMed ID: 22653739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of free PSA in early detection of prostate cancer.
    Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
    Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays.
    Vessella RL; Lange PH; Partin AW; Chan DW; Sokoll LJ; Sasse EA; Crawford ED
    Urology; 2000 Jun; 55(6):909-14. PubMed ID: 10840107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.
    Catalona WJ; Southwick PC; Slawin KM; Partin AW; Brawer MK; Flanigan RC; Patel A; Richie JP; Walsh PC; Scardino PT; Lange PH; Gasior GH; Loveland KG; Bray KR
    Urology; 2000 Aug; 56(2):255-60. PubMed ID: 10925089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
    Becker C; Piironen T; Pettersson K; Hugosson J; Lilja H
    J Urol; 2003 Oct; 170(4 Pt 1):1169-74. PubMed ID: 14501718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL.
    Berger AP; Cheli C; Levine R; Klocker H; Bartsch G; Horninger W
    Urology; 2003 Nov; 62(5):840-4. PubMed ID: 14624905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.
    Becker C; Piironen T; Pettersson K; Hugosson J; Lilja H
    Urology; 2000 May; 55(5):694-9. PubMed ID: 10792083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign.
    Cheli CD; Levine RL; Cambetas DR; Kolker JD; Roberts SB
    Urology; 2002 Oct; 60(4 Suppl 1):53-9. PubMed ID: 12384164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
    Bruun L; Björk T; Lilja H; Becker C; Gustafsson O; Christensson A
    Nephrol Dial Transplant; 2003 Mar; 18(3):598-603. PubMed ID: 12584285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A preliminary study of PSA level in 646 healthy men in Beijing].
    Shao Q; Guo Y; Guo H
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):591-2. PubMed ID: 11798824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics.
    Miller MC; O'Dowd GJ; Partin AW; Veltri RW
    Urology; 2001 Jun; 57(6):1105-11. PubMed ID: 11377319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.
    Babaian RJ; Fritsche H; Ayala A; Bhadkamkar V; Johnston DA; Naccarato W; Zhang Z
    Urology; 2000 Dec; 56(6):1000-6. PubMed ID: 11113747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
    Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients.
    Liao CH; Liu SP; Pu YS; Huang CY; Yu HJ; Chen J
    J Formos Med Assoc; 2001 Feb; 100(2):113-9. PubMed ID: 11393098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.